| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |